Quick Takeaways
- Stuart Holden has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $39,560.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Stuart Holden
- Location
- Ra'anana, Israel
- Summary
- The estimated net worth of Stuart Holden is at least $39,560 dollars as of 01 Dec 2025. Stuart Holden is the Director of UroGen Pharma Ltd. and owns shares of UroGen Pharma Ltd. (URGN) stock worth about $39.6K.
- Signature
- /s/ Jason D. Smith, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Stuart Holden and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
What Changed
- Largest disclosed position: UroGen Pharma Ltd. ($39,560).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Stuart Holden
URGN
Forms 3/4/5
UroGen Pharma Ltd.
- Relationship
- Director
- Holdings value
- $39,560
- Past year net change
- Change %
- Report period
- 26 Nov 2025
Insider Transactions Reported by Stuart Holden:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.